Detection of serum anti-p53 antibodies from patients with ovarian cancer in China: Correlation to clinical parameters

Cancer Investigation

Volumn 25, Issue 7, 2007, Pages 563-568

  Qiu, Tian ^a   Yang, Qiong ^a   Li, Xing Rong ^a   Yang, Hua ^b   Qiu, Lin Lin ^a   Wang, Li ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Antibodies; ELISA; Ovarian cancer; p53; Phage display

Indexed keywords

EPITOPE; PROTEIN P53; RECOMBINANT PROTEIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PHAGE DISPLAY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIBODIES; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PEPTIDE LIBRARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 36348953856     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701515434     Document Type: Article

References (25)

1. Wingo, P.A.; Tong, T.; Bolden, S. Cancer statistics, 1995. C.A. Cancer. J. Clin. 1995, 45, 8-30.
2. Chen, P.L.; Chen, Y.M.; Bookstein, R.; Lee, W.H. Genetic mechanisms of tumor suppression by the human p53 gene. Science. 1990, 1576-1580.
3. Davidoff, A.M.; Iglehart, J.D.; Marks, J.R. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA. 1992, 89(8), 3439-3442.
4. Crawford, L.V.; Pim, D.C.; Bulbrook, R.D. Detection of antibodies against the cellular protein p53 in sera of patients with breast cancer. Int J Cancer. 1982, 30(4), 403-408.
5. Angelopoulou, K.; Diamandis, E.P.; Sutherland, D.J.; Kellen, J.A.; Bunting, P.S. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. Int J Cancer. 1994, 58(4), 480-487.
6. Soussi, T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000, 60(7), 1777-1788.
7. Goodell, V.; Salazar, L.G.; Urban, N.; Drescher, C.W.; Gray, H.; Swensen, RE; McIntosh, MW; Disis, ML. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer. J Clin Oncol. 2006, 24(5), 762-768.
8. Angelopoulou, K.; Rosen, B.; Stratis, M.; Yu, H.; Solomou, M.; Diamandis, E.P. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival. Cancer. 1996, 78(10), 2146-2152.
9. Lubin, R.; Schlichtholz, B.; Bengoufa, D.; et al. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. Cancer Res. 1993, 53(24), 5872-5876.
10. Portefaix, J.M.; Fanutti, C.; Granier, C.; Crapez, E.; Perham, R.; Grenier, J.; Pau, B.; Del Rio, M. Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides. J Immunol Methods. 2002, 259(1-2), 65-75.
11. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol 1987, 156(1), 263-264.
12. Gao, R.J.; Bao, H.Z.; Yang, Q.; Cong, Q.; Song, J.N.; Wang, L. The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters. Breast Cancer Research and Treatment. 2005, 93(2), 111-115.
13. Vogl, F.D.; Stickeler, E.; Weyermann, M.; Vogl, FD.; Stickeler, E.; Weyermann, M.; Kohler, T.; Grill, HJ.; Negri, G.; Kreienberg, R.; Runnebaum, I.B. p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells. Oncology. 1999, 57(4), 324-329.
14. Green, J.A.; Robertson, L.J.; Campbell, I.R.; Jenkins, J. Expression of the p53 gene and presence of serum autoantibodies in ovarian cancer: correlation with differentiation. Cancer Detect Prev. 1995, 19(2), 151-155.
15. Angelopoulou, K.; Rosen, B.; Stratis, M.; Yu, H.; Solomou, M.; Diamandis, E.P. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival. Cancer. 1996, 78(10), 2146-2152.
16. Gadducci, A.; Ferdeghini, M.; Buttitta, F.; Cosio, S.; Fanucchi, A.; Annicchiarico, C.; Gagetti, O.; Bevilacqua, G.; Genazzani, A.R. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol. 1999, 72(1), 76-81.
17. di Marzo Veronese, F.; Willis, A.E.; Boyer-Thompson, C.; Appella, E.; Perham, R.N. Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120. J Mol Biol. 1994, 243(2), 167-172.
18. DePriest, P.D.; Gallion, H.H.; Pavlik, E.J.; Kryscio, R.J.; van Nagell, J.R. Jr. Transvaginal sonography as a screening method for the detection of early ovarian cancer. Gynecol Oncol. 1997, 65(3), 408-414.
19. Vogl, F.D.; Frey, M.; Kreienberg, R.; Runnebaum, I.B. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer. 2000, 83(10), 1338-1343.
20. Gadducci, A.; Ferdeghini, M.; Buttitta, F.; Cosio, S.; Fanucchi, A.; Annicchiarico, C.; Gagetti, O.; Bevilacqua, G.; Genazzani, A.R. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol. 1999, 72(1), 76-81.
21. Fujita, M.; Enomoto, T.; Murata, Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol. 2003, 202(1-2), 97-99.
22. Tarapore, P.; Fukasawa, K. p53mutation and mitotic infidelity. Cancer Invest. 2000, 18(2), 148-155.
23. Watanabe, J.; Nishiyama, H.; Kawanishi, H.; Ito, M.; Kamoto, T.; Ogawa, O. Clinical evaluation of serum p53 antibodies in patients with upper urinary tract tumors. J Urol. 2005, 174(1), 73-75.
24. Limpaiboon, T.; Sripa, B.; Wongkham, S.; Bhudhisawasdi, V.; Chau-in, S.; Teerajetgul, Y. Anti-p53 antibodies and p53 protein expression in cholangiocarcinoma. Hepatogastroenterology. 2004, 51(55), 25-28.
25. Gumus, E.; Erdamar, S.; Demirel, G.; Horasanli, K.; Kendirci, M.; Miroglu, C. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients. Int J Urol. 2004, 11(12), 1070-1077.